Disclosure Of Entity's Operating Segments [Text Block]

Pharming Group N.V. - Filing #1859781

Concept 2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
As at
2019-12-31
Disclosure of entity's operating segments [text block]
Disclosure of operating segments [text block]
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Revenue
198,871,000 USD
212,174,000 USD
Tax expense (income)
7,082,000 USD
6,348,000 USD
Profit (loss) before tax
23,078,000 USD
44,094,000 USD
Profit (loss)
USD
USD
USD
USD
USD
USD
15,996,000 USD
15,996,000 USD
37,746,000 USD
37,746,000 USD
USD
USD
USD
USD
USD
USD
Assets
397,315,000 USD
418,453,000 USD
255,915,000 USD
Investments accounted for using equity method
7,201,000 USD
7,118,000 USD
6,177,000 USD
Cash flows from (used in) operating activities
37,842,000 USD
83,626,000 USD
Cash flows from (used in) investing activities
21,305,000 USD
15,629,000 USD
Cash flows from (used in) financing activities
27,947,000 USD
60,686,000 USD
Disclosure of products and services [text block]
Disclosure of products and services [abstract]
Disclosure of products and services [line items]
Disclosure of geographical areas [text block]
Disclosure of geographical areas [abstract]
Disclosure of geographical areas [line items]
Disclosure of major customers [text block]
Disclosure of major customers [abstract]
Disclosure of major customers [line items]

Talk to a Data Expert

Have a question? We'll get back to you promptly.